IM Vaccine http://imvaccine.com/ IM Vaccine News Feed vaccine, cancer, medical techsupport@impactcommuncations.ca Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013 http://imvaccine.com/releases.php?releases_id=300 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013 Immunovaccine Announces Results of 2013 Annual General Meeting http://imvaccine.com/releases.php?releases_id=299 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Announces Results of 2013 Annual General Meeting Immunovaccine Receives Financial Contribution from the Government of Canada to Provide Support towards Clinical Studies in Common Respiratory Illness Affecting Both Children and the Elderly http://imvaccine.com/releases.php?releases_id=298 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Receives Financial Contribution from the Government of Canada to Provide Support towards Clinical Studies in Common Respiratory Illness Affecting Both Children and the Elderly Immunovaccine Announces 2012 Year-End Results http://imvaccine.com/releases.php?releases_id=297 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Announces 2012 Year-End Results Immunovaccine Closes Private Placement Financing at $1.6 Million http://imvaccine.com/releases.php?releases_id=296 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Closes Private Placement Financing at $1.6 Million Immunovaccine Provides Update on Private Placement Financing http://imvaccine.com/releases.php?releases_id=295 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Provides Update on Private Placement Financing Immunovaccine Announces Financing Plans http://imvaccine.com/releases.php?releases_id=294 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Announces Financing Plans Immunovaccine Announces a Proposed Equity Offering http://imvaccine.com/releases.php?releases_id=293 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Announces a Proposed Equity Offering Immunovaccine Signs Agreement for Phase I/II Clinical Trial of DPX-0907 in Breast and Ovarian Cancer Patients http://imvaccine.com/releases.php?releases_id=292 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine Signs Agreement for Phase I/II Clinical Trial of DPX-0907 in Breast and Ovarian Cancer Patients Immunovaccine’s DPX-Survivac Produces Sustained, Dose Related Immune Responses in Phase I Ovarian Cancer Study http://imvaccine.com/releases.php?releases_id=291 Wed, 31 Dec 1969 19:00:00 EST Immunovaccine’s DPX-Survivac Produces Sustained, Dose Related Immune Responses in Phase I Ovarian Cancer Study